Stanford-designed molecule turns a lymphoma driver into a cancer kill switch
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Stanford Medicine researchers created a two-part molecule that links a protein driving B-cell lymphoma to another protein that activates programmed cell death. Twice-daily treatment eliminated aggressive human lymphoma tumors in mice within 11 days, but further testing is required.
Continue in the app — vote & join in ➔Source: ScienceDaily · via ahirlevel.hu